Media OutReach

Sanofi sets Singapore Book of Records with the ‘Largest Mural of Magnetic Hands’ – a Public Pledge against Respiratory Syncytial Virus (RSV) in Nationwide Awareness Campaign

Published

5 months ago

13/10/2025

Sanofi has achieved a new Singapore Book of Records milestone featuring more than 1,000 RSV awareness pledges.
The Together Against RSV campaign unites families, healthcare partners and communities to spotlight the risks of RSV and its impact on all infants.
Each magnetic hand symbolises a pledge of protection, creating an impactful visual reminder of the nation’s shared commitment to safeguarding young children’s health against RSV.

SINGAPORE – Media OutReach Newswire – 13 October 2025 – Sanofi has made history with a nationwide public health activation by clinching a spot in the Singapore Book of Records with the ‘Largest Mural of Magnetic Hands’, a public pledge against Respiratory Syncytial Virus (RSV) in its Together Against RSV campaign. The striking mural featured a total of over 1,000 hand pledges, each representing a parent, caregiver, or supporter who committed to raising awareness of Respiratory Syncytial Virus (RSV) – a common yet potentially serious virus – and protecting all infants from its risks.

(L to R: Ruby Dizon, Vaccines Medical Head, Sanofi SEA & India, Dr Adrian Tan, Founder & Medical Director of Babysteps Medical and Babysteps & Beyond Family & Child Clinic, Mr Ong Eng Huat, Founder & President of Singapore Book of Record, Zainab Sadat, Vaccines General Manager, Sanofi SEA & India and Eric Mansion, Pharma General Manager & MCO Lead, Sanofi SEA & India)

Over the three-day event at Serangoon NEX, families, healthcare partners, and community members came together to symbolically place hand-shaped magnets on a panelled mural, with each hand carrying a personal pledge of commitment to learning about and fighting against RSV.

Zainab Sadat, Head of Vaccines, Sanofi Southeast Asia & India

“This record is more than just numbers; it is a symbol of unity and a testament to the collective power of Singaporean families, healthcare professionals, and communities coming together for a cause that truly matters. Through our ‘Together Against RSV’ campaign, we hope to spark ongoing conversations about RSV and empower parents with knowledge and preventive measures, including immunisation options, to protect their little ones. Together, we are building a future where every baby can breathe a little easier, and every family can rest a little more peacefully.”

The mural, measuring 2 meters tall by 5.1 meters wide, now serves as a striking visual reminder of the nation’s shared commitment to combating RSV. The event also complemented wider awareness initiatives, including collaborations with hospitals, parent communities, and an educational microsite (TogetherAgainstRSV.sg) in collaboration with the Singapore Paediatric Society, as part of Sanofi’s mission to empower parents with trusted information and preventive solutions.

Around the world, about two in three infants contract RSV before their first birthday¹, making it the most common cause of lower respiratory tract infections, including bronchiolitis and pneumonia, in young children². In Singapore, RSV is also a leading cause of infant hospitalisations, with the majority of cases occurring in otherwise healthy, full-term babies. Each year, an estimated 1,804 children under 29 months are hospitalised due to RSV-related illness^3-7.

Hashtag: #Sanofi

The issuer is solely responsible for the content of this announcement.

About RSV

RSV is a highly contagious virus that can lead to serious respiratory illness for infants.² It is a leading cause of hospitalisation in all infants, with most hospitalisations for RSV occurring in otherwise healthy infants born at term^3-7. Two out of three infants are infected with RSV during their first year of life and almost all children are infected by their second birthday¹. Globally, in 2019, there were approximately 33 million cases of acute lower respiratory infections leading to more than three million hospitalisations, and it was estimated that there were 26,300 in-hospital deaths of children younger than five years⁸. RSV-related direct medical costs, globally — including hospital, outpatient and follow-up care — were estimated at €4.82 billion in 2017⁹.

About Sanofi

Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time.

For more information, visit www.sanofi.com.

Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that pandemics or other global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2022. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

References

Walsh, EE. Respiratory Syncytial Virus Infection: An Illness for All Ages. Clinics in Chest Medicine. 2017;38(1):29-36.
Karron A. Respiratory Syncytial Virus Vaccines and Monoclonal antibodies. Orenstein W, Offit P, Edwards KM, Plotkin S. Plotkin’s Vaccines, eighth edition: 998-1004. Elsevier 2023.
Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(5 Suppl):S127-S132. doi:10.1067/s00223476(03)00510-9.
Zhou H, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54:1427–1436.
Rha B, et al. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020;146:e20193611.
Arriola CS, et al. Estimated Burden of Community-Onset Respiratory Syncytial Virus-Associated Hospitalizations Among Children Aged <2 Years in the United States, 2014-15. J Pediatric Infect Dis Soc. 2020;9:587-595
Tam CC, et al. Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore. Emerg Infect Dis. 2020 Jul;26(7):1489-1496
Li Y, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022;399:92047–64.
Zhang S, et al. Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. J Infect Dis. 2020;222(Suppl 7):S680-687.

MAT-SG-2500364-1.0-10/202

Media OutReach

AECOM supports CEDD and AFCD of HKSAR Government in launching Hong Kong’s first comprehensive nature-based solutions guidelines to advance sustainable urban development

Published

24 hours ago

10/03/2026

Media Outreach

HONG KONG SAR – Media OutReach Newswire – 10 March 2026 – AECOM, the trusted global infrastructure leader, supported the release of the Hong Kong Nature-based Solutions Design Guidelines (HKNbSDG), a first-of-its-kind guidelines developed for the Civil Engineering Development Department (CEDD) and the Agriculture, Fisheries and Conservation Department (AFCD) of the HKSAR Government. The HKNbSDG helps government agencies, designers, planners and built environment professionals in integrating nature-based solutions (NbS) into urban development projects across Hong Kong.

Developed through multidisciplinary expertise in ecology, landscape architecture, engineering, climate resilience and urban planning, the HKNbSDG provides a practical blueprint for designing, implementing, sustainably managing, and evaluating NbS across diverse environmental contexts — from rivers and wetlands to coastlines and high-density urban districts.

Factoring in the characteristics of Hong Kong’s natural ecology and urban development, the HKNbSDG is built on three core principles that outline a holistic approach to promoting ecosystem diversity at multiple scales, embracing human-nature coexistence for mutual benefits, and improving resilience through NbS. It also includes a performance evaluation framework to support evidence-based decision-making and features local case studies, including Long Valley Nature Park and Tung Chung East Eco-shoreline.

“The HKNbSDG reflects our commitment to advancing nature‑positive design and supporting Hong Kong’s journey toward climate resilience and sustainable growth,” said Dr. Johnny Cheuk, senior vice president and Hong Kong executive leader at AECOM. “By integrating ecological science into design practice, we aim to empower practitioners to harness nature’s potential in building climate-resilient infrastructure.”

The HKNbSDG was officially launched at the Promulgation Ceremony held on March 3, 2026, at Long Valley Nature Park. The event was officiated by Miss. Diane Wong Shuk-han, JP, Under Secretary for Environment and Ecology; Mr. David Lam Chi-man, JP, Under Secretary for Development; Mr. Charles Karangwa, Global Head of Nature-based Solutions Centre of the International Union for Conservation of Nature (IUCN); Ir Michael Fong Hok-shing, JP, Director of Civil Engineering and Development; and Mr. Mickey Lai Kin-ming, JP, Director of Agriculture, Fisheries and Conservation.

The ceremony featured an introduction to the HKNbSDG by Stephen Suen, director of landscape architecture at AECOM, followed by a panel discussion on building cross-sector partnerships to reverse nature and biodiversity loss through NbS.

Panelists included:

Mr. Charles Karangwa, Global Head, Nature-based Solutions Centre, IUCN
Ir. Michael Fong Hok‑shing, JP, Director of Civil Engineering and Development
Mr. Mickey Lai Kin Ming, JP, Director of Agriculture, Fisheries and Conservation
Ms. Frances Chen, Director, Sustainability & Climate Change, North Asia, HSBC
Mr. Benny Au, Senior Manager, Sustainable Development, Swire Properties Limited

The release of the HKNbSDG supports Hong Kong’s key policy commitments, including the Climate Action Plan 2050 and its biodiversity conservation targets, by providing a practical roadmap for enhancing urban resilience and expanding green infrastructure. This publication equips practitioners with essential tools — from integrating ecology into early planning to designing for multifunctional benefits — grounded in Hong Kong-specific experience. It also serves as a central resource for advancing the Northern Metropolis development strategy, where NbS is helping to drive urban-rural integration and foster the co-existence of urban development and ecological conservation.

The HKNbSDG forms part of AECOM’s broader mission to help cities adapt to climate risks while enhancing quality of life. By bringing together global best practices and local ecological insights, AECOM aims to strengthen industry-wide capability in implementing NbS at scale.

Learn more about the Hong Kong Nature-based Solutions Design Guidelines here.

Download high-resolution images here.

Hashtag: #AECOM #NatureBasedSolutions #NaturePositive #ClimateResilience #Biodiversity

The issuer is solely responsible for the content of this announcement.

About AECOM

AECOM is the global infrastructure leader, committed to delivering a better world. As a trusted professional services firm powered by deep technical abilities, we solve our clients’ complex challenges in water, environment, energy, transportation and buildings. Our teams partner with public- and private-sector clients to create innovative, sustainable and resilient solutions throughout the project lifecycle – from advisory, planning, design and engineering to program and construction management. AECOM is a Fortune 500 firm that had revenue of US$16.1 billion in fiscal year 2025. Learn more at AECOM.

Media OutReach

Asian Computer Industry Online Exhibition 2026: A Global Hub for Technology Industry Collaboration

Published

24 hours ago

10/03/2026

Media Outreach

TAIPEI, TAIWAN –

Since its launch in 2022, the exhibition has been jointly organized by AsianNet and TradeAsia (www.e-tradeasia.com). The event has supported numerous companies in expanding into overseas markets and has earned strong industry recognition for high-quality buyers, efficient matchmaking, and measurable order results.

In 2026, ACI 2026 will expand in scale and be held concurrently with leading international technology trade shows, including Embedded World, Display Week (SID), COMPUTEX TAIPEI, and ISC High Performance. By aligning with major global exhibitions, the event creates a strong time-synergy effect, enabling international buyers to efficiently compare products, evaluate suppliers, and complete procurement decisions within a concentrated timeframe. This strategic alignment enhances purchasing efficiency and maximizes cross-exhibition business opportunities.

ACI 2026 features a robust lineup of respected Taiwanese manufacturers, including industry leaders such as HIGHGRADE TECH, OKAYO ELECTRONICS, BIPOLAR ELECTRONIC, YNG WEI, YNG YUH ELECTRONIC, ESMT, GOOD OPPORTUNITY ELECTRONIC, MSTRONIC, SUN RISE EXACT, AIRWAVE TECHNOLOGIES, KING DESGIN INDUSTRIAL, CLEVER INTELLIGENCE UNITY, YO-TRONICS TECHNOLOGY, DORIS INDUSTRIAL, REUEX INDUSTRIAL, ARIOSE ELECTRONICS, UNITEX NUNG LAI BUTTON and many more. These companies will present thousands of the latest computer industry products and technologies, covering a wide array of sectors crucial to modern manufacturing and production.

Comprehensive Coverage Across the Entire Industry Chain

The Asian Computer Industry Online Exhibition 2026 brings together dozens of premium suppliers from the global computer manufacturing and electronic components sectors, showcasing over a thousand innovative products and forward-looking technologies. The exhibits are strategically structured around the core value of the industry supply chain, comprehensively covering key system-level products such as desktop computers, laptops and accessories, tablets and accessories, industrial computers and embedded systems, gaming and e-sports equipment, as well as computer software, IT, and internet services.

The ACI 2026 also highlights critical communications infrastructure, including networking equipment, wireless communication devices, telecommunications and fiber access equipment, landline and VoIP systems, and antennas. In terms of key components and supply chain solutions, the showcased products include computer components, storage and memory devices, active components, power supply units, connectors and terminals, cables and cable assemblies, wiring accessories, transformers, batteries, and charging equipment.

In addition, the ACI 2026 features monitors, computer accessories and peripherals, input devices, point-of-sale (POS) systems, printers, plotters and scanners, printer consumables and parts, as well as broadcast and professional AV equipment, audio and video components, consumer electronics accessories and components, and electronic materials and supplies.

Together, these comprehensive categories fully demonstrate the complete ecosystem of the computer industry, spanning system integration, communications infrastructure, core components, and end-use applications. Combining technological depth with product breadth, the exhibition stands as a premier international trade event for efficient business matchmaking and global market expansion among professional buyers and industry stakeholders worldwide.

ACI 2026 Online Exhibition：
https://www.etradeasia.com/online-show/43/Asian-Computer-Industry-Online-Exhibition-2026.html

Innovative Online Exhibition Model

The Asian Computer Industry Online Exhibition 2026 features dedicated online showrooms, digital catalogs, and virtual exhibition halls fully integrated with the TradeAsia platform. Buyers worldwide can browse exhibitor information, submit quotation requests, and conduct procurement evaluations in real time, thereby facilitating efficient, cost-effective, and results-driven global business connections.

Hashtag: #TradeAsia

The issuer is solely responsible for the content of this announcement.

About TradeAsia

TradeAsia (www.e-tradeasia.com) is a well-established global B2B trade platform with millions of members and over 600,000 suppliers worldwide. The platform facilitates efficient matchmaking between buyers and sellers and maintains strategic partnerships with hundreds of trade organizations and exhibition entities globally. Through cross-platform marketing and integrated exposure, TradeAsia provides suppliers with expanded international visibility and multi-channel promotion opportunities. For ACI 2026, the organizers will implement a comprehensive global marketing campaign to support exhibitors in expanding overseas markets, enhancing brand presence, and maximizing business opportunities.

Media OutReach

ABP Securite Announces Strategic Partnership With Rapid7 to Enhance Cybersecurity in Asia Pacific

Published

1 day ago

10/03/2026

Media Outreach

SINGAPORE – Media OutReach Newswire – 10 March 2026 – ABP Securite Pte Ltd, a global Value-Added Distributor (VAD) specialising in cybersecurity and network performance solutions, today announced a new strategic partnership with global cybersecurity company Rapid7, Inc. to accelerate the adoption of intelligence-led exposure management and modern threat detection solutions across Singapore and Malaysia.

The collaboration marks an important step in enabling enterprises to strengthen their security posture amid the region’s rapidly expanding digital landscape. With evolving hybrid infrastructures, accelerated cloud transformation, and increasing threat complexity, organisations across Asia Pacific are seeking more comprehensive ways to gain visibility, prioritise risk, and streamline response.

Under this partnership, ABP Securite will distribute and support Rapid7’s cybersecurity portfolio across Asia Pacific— including the Rapid7 Command Platform covering exposure management, SIEM and XDR, cloud security, application security, automation, and external threat intelligence.

Closing the Cyber Visibility Gap

“As the cybersecurity threat surface in Asia Pacific continues to grow, visibility and control have become mission critical,” said Joyce Ng, Chief Executive Officer of ABP Securite. “At ABP Securite, our role is to help customers turn complexity into clarity. Partnering with Rapid7 brings a best-in-class platform that empowers security teams to quantify and reduce risk more effectively. Together, we can help organisations operationalise cyber resilience and protect their most valuable assets.”

Jason Heng, Regional Sales Director, ASEAN at Rapid7, added, “ABP Securite has built a strong reputation for enabling regional partners and customers with advanced cybersecurity technologies. Through this collaboration, Rapid7 gains a powerful ally to extend our reach and help organisations in Asia Pacific gain real-time insight into their exposure, simplify operations, and respond faster to emerging threats.”

Hashtag: #ABPSecurite

The issuer is solely responsible for the content of this announcement.

About ABP Securite Pte Ltd

ABP Securite Pte Ltd is a leading cybersecurity and network-performance Value-Added Distributor (VAD), incorporated in 2015 and headquartered in Singapore, with regional offices across Asia Pacific. The company delivers a comprehensive portfolio of advanced security technologies and professional services — including architecture advisory, solution integration, after-sales support, and cloud-managed services. ABP Securite collaborates with a broad ecosystem of partners to help organisations strengthen cyber resilience, secure infrastructure, and protect critical assets across cloud, network, and data environments.
Website: www.abpsecurite.com

About Rapid7

Rapid7, Inc. (NASDAQ: RPD) is a global leader in AI-powered managed cybersecurity operations, trusted to advance organizations’ cyber resilience. Open and extensible, the Rapid7 Command Platform integrates security data, enriching it with AI, threat intelligence, and 25 years of expertise and innovation to reduce risk and disrupt attackers. As a recognized leader in preemptive managed detection and response (MDR), Rapid7 unifies exposure and detection to transform the cybersecurity operations of more than 11,500 customers worldwide. For more information, visit our website, check out our blog, or follow us on LinkedIn or X.